Structures by: Akkurt M.
Total: 604
2-[(2-Chlorophenyl)iminomethyl]-4,6-dimethylquinoline
C18H15ClN2
Acta Crystallographica Section E (2001) 57, 8 o730-o732
a=7.4962(7)Å b=9.5511(9)Å c=11.4013(11)Å
α=79.039(2)° β=76.866(2)° γ=76.886(2)°
4,6-Dimethyl-2-(o-tolyliminomethyl)quinoline
C19H18N2
Acta Crystallographica Section E (2001) 57, 5 o454-o455
a=7.5693(7)Å b=9.5620(9)Å c=11.3908(11)Å
α=79.203(2)° β=76.735(2)° γ=77.514(2)°
1-Benzyl-3-(2-phenethyl)benzimidazolium bromide monohydrate
C22H20N2,Br,H2O
Acta Crystallographica Section E (2005) 61, 8 o2452-o2454
a=9.2334(9)Å b=9.3684(10)Å c=11.3028(12)Å
α=99.895(8)° β=90.607(8)° γ=95.637(8)°
6-Methyl-N-(3-oxo-1-thia-4-azaspiro[4.4]non-4-yl)imidazo[2,1-b][1,3]thiazole- 5-carboxamide monohydrate
C14H16N4O2S2,H2O
Acta Crystallographica Section E (2005) 61, 8 o2357-o2359
a=12.959(5)Å b=10.908(5)Å c=23.797(5)Å
α=90° β=90° γ=90°
3-Isopropyl-1-[2-(pyrrolidinium-1-yl)ethyl]benzimidazolium diodide
C16H25N32,2I
Acta Crystallographica Section E (2006) 62, 1 o185-o187
a=11.639(5)Å b=12.945(5)Å c=13.192(5)Å
α=90° β=94.349(5)° γ=90°
1-Ethyl-3-(2-phenylethyl)benzimidazole-2-selone
C17H18N2Se
Acta Crystallographica Section E (2004) 60, 7 o1263-o1265
a=7.6427(5)Å b=12.7380(12)Å c=15.5045(9)Å
α=90° β=90° γ=90°
1-Ethyl-4-phenylethyl-1,4-dihydroquinoxaline-2,3-dione
C18H18N2O2
Acta Crystallographica Section E (2004) 60, 7 o1266-o1268
a=13.369(5)Å b=15.310(5)Å c=14.690(5)Å
α=90° β=90° γ=90°
Trans,trans,trans-2,3,5,8-Tetrabromo-1,4-dihydroxy-1,2,3,4- tetrahydronaphthalene
C10H8Br4O2
Acta Crystallographica Section E (2004) 60, 11 o2096-o2098
a=16.8495(9)Å b=12.1086(9)Å c=12.3570(7)Å
α=90° β=90° γ=90°
3,3'-Bis(cyclohexylmethyl)-1,1'-propylenedibenzimidazolium dibromide monohydrate
C31H42N42,2Br,H2O
Acta Crystallographica Section E (2006) 62, 8 o3184-o3186
a=9.2538(5)Å b=12.5925(8)Å c=15.4610(9)Å
α=105.049(5)° β=105.593(4)° γ=110.034(4)°
N-(2-Hydroxy-3-methoxybenzylidene)-2,3,4,6-tetra-O-acetyl-β-D- galactopyranosylamine
C22H27NO11
Acta Crystallographica Section E (2006) 62, 8 o3247-o3248
a=8.6855(7)Å b=7.6735(5)Å c=18.5577(15)Å
α=90° β=97.124(7)° γ=90°
5-Furan-2-yl-1,3,4-oxadiazole-2(3H)-thione
C6H4N2O2S
Acta Crystallographica Section E (2004) 60, 3 o322-o323
a=5.194(5)Å b=20.102(5)Å c=6.914(5)Å
α=90° β=102.573(5)° γ=90°
3-(6-Benzoyl-5-chloro-2-oxo-2,3-dihydro-1,3-benzoxazol-3-yl)propanoic acid
C17H12ClNO5
Acta Crystallographica Section E (2004) 60, 3 o341-o343
a=26.015(10)Å b=6.252(5)Å c=20.412(4)Å
α=90° β=109.749(16)° γ=90°
Ethyl 3-methyl-1-oxo-4H-1,4-benzothiazine-2-carboxylate
C12H13NO3S
Acta Crystallographica Section E (2005) 61, 8 o2716-o2717
a=12.9935(13)Å b=33.042(4)Å c=11.1555(13)Å
α=90° β=90° γ=90°
3,3'-Bis(3-cyanopropyl)-1,1'-propylenedi(benzimidazolium) dichloride dihyrate
C25H28N62,2Cl1,2H2O
Acta Crystallographica Section E (2003) 59, 6 o786-o788
a=10.5530(17)Å b=11.0533(18)Å c=13.494(2)Å
α=71.698(3)° β=75.434(3)° γ=63.279(2)°
1-(12-benzoyl-10-oxa-12-azatetracyclo[6.3.1.0^2,7^.0^9,11^] dodeca-2,4,6-trien-1-yl)ethan-1-one
C19H15NO3
Acta Crystallographica Section E (2003) 59, 5 o635-o637
a=7.8290(10)Å b=13.8740(10)Å c=14.0790(10)Å
α=90° β=90° γ=90°
C7H7N2O6
C7H7N2O6
Acta Crystallographica Section E (2003) 59, 4 o550-o552
a=13.4146(9)Å b=6.6414(5)Å c=10.0118(6)Å
α=90° β=90° γ=90°
5-(2-Furyl)-4-(4-methoxyphenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione
C13H11N3O2S
Acta Crystallographica Section E (2004) 60, 12 o2368-o2370
a=7.0789(6)Å b=8.4650(6)Å c=21.4774(13)Å
α=90° β=96.492(5)° γ=90°
Dichlorobis[1-(2-ethoxyethyl)-1H-benzimidazole-κN^3^]nickel(II)
C22H28Cl2N4NiO2
Acta Crystallographica Section E (2005) 61, 1 m41-m43
a=17.416(5)Å b=7.624(5)Å c=17.667(5)Å
α=90° β=90° γ=90°
1-[2-(5-Nitrobenzimidazol-1-yl)ethyl]morpholinium chloride
C13H17N4O3,Cl
Acta Crystallographica Section E (2005) 61, 1 o166-o168
a=7.0522(5)Å b=9.9537(8)Å c=9.9895(7)Å
α=83.607(6)° β=80.386(6)° γ=89.477(6)°
6-Methyl-N'-(1-methylethylidene)imidazo[2,1-b][1,3]thiazole-5-carbohydrazide monohydrate
C10H12N4OS,H2O
Acta Crystallographica Section E (2005) 61, 3 o718-o720
a=10.0955(7)Å b=9.8500(6)Å c=13.3756(8)Å
α=90° β=111.226(5)° γ=90°
N-(2,2-Dimethyl-4-oxo-1,3-thiazolidin-3-yl)-6- methylimidazo[2,1-b][1,3]thiazole-5-carboxamide monohydrate
C12H14N4O2S2,H2O
Acta Crystallographica Section E (2005) 61, 4 o892-o894
a=11.3660(7)Å b=21.4096(12)Å c=12.9034(11)Å
α=90° β=90° γ=90°
Poly[[triaquacadmium(II)-μ~3~-lactato] dilactatoboron(1-)]
C3H11CdO6,C6H8BO6
Acta Crystallographica Section E (2005) 61, 4 m632-m634
a=8.424(5)Å b=10.184(5)Å c=20.943(5)Å
α=90° β=90° γ=90°
3-Phenoxy-1,4-diphenylazetidin-2-one
C21H17NO2
Acta Crystallographica Section E (2006) 62, 3 o866-o868
a=6.0985(9)Å b=9.5020(16)Å c=15.318(2)Å
α=74.815(12)° β=87.578(12)° γ=73.355(12)°
N-Benzyl-indole-2,3-dione(N-benzylisatin)
C15H11NO2
Acta Crystallographica Section E (2006) 62, 4 o1575-o1577
a=7.610(3)Å b=11.311(2)Å c=13.422(4)Å
α=90° β=90.16(3)° γ=90°
1-naphthylamino-2-benzoyl-3-phenyl-3-hydroxy-2-propene-1-one
C26H19NO3
Acta Crystallographica Section C (1998) 54, 6 IUC9800023
a=9.9862(5)Å b=12.3722(5)Å c=16.0829(7)Å
α=90.00° β=92.777(2)° γ=90.00°
C17H13N3OS
C17H13N3OS
Acta Crystallographica Section C (1992) 48, 2 315-317
a=9.712(3)Å b=15.072(3)Å c=10.713(3)Å
α=90° β=107.65(3)° γ=90°
C26H22N4O2
C26H22N4O2
Acta Crystallographica Section C (1993) 49, 4 747-749
a=9.564(2)Å b=11.3050(10)Å c=20.389(3)Å
α=90° β=91.270(10)° γ=90°
5-benzoyl-1-ethyl-4-phenylpyrimidine-2-one
C19H16N2O2
Acta Crystallographica Section C (1999) 55, 1 97-99
a=8.4254(4)Å b=17.2278(6)Å c=10.9291(3)Å
α=90.00° β=96.164(2)° γ=90.00°
Dichlorido(4,4-di-<i>tert</i>-butyl-2,2'-bipyridine- κ^2^<i>N</i>,<i>N</i>')gold(III) tetrachloroaurate(III) acetonitrile solvate
C18H24AuCl2N2,AuCl4,C2H3N
Acta Crystallographica Section E (2008) 64, 9 m1189-m1190
a=6.7880(9)Å b=14.2270(19)Å c=14.1330(19)Å
α=90° β=97.151(2)° γ=90°
N-(4-Chlorophenyl)-N-(4,5-dihydro-1H-imidazol-2-yl)amine formamide solvate
C9H10ClN3,CH3NO
Acta Crystallographica Section E (2007) 63, 5 o2130-o2132
a=8.5840(5)Å b=13.2740(4)Å c=9.9080(7)Å
α=90° β=105.789(5)° γ=90°
(1,3-Benzothiazol-2-yl)[1-(2-chlorobenzyl)imidazolidin-2-ylidene]amine
C17H15ClN4S
Acta Crystallographica Section E (2006) 62, 9 o3812-o3813
a=20.0595(3)Å b=10.6269(2)Å c=15.0647(2)Å
α=90° β=97.5720(10)° γ=90°
C37H31N3O2
C37H31N3O2
Acta Crystallographica Section E (2006) 62, 11 o5022-o5023
a=11.6063(7)Å b=14.8988(6)Å c=19.4799(11)Å
α=90° β=121.552(4)° γ=90°
1,2-bis(2-aminophenoxy)ethane
C14H16N2O2
Acta Crystallographica Section E (2007) 63, 1 o331-o332
a=7.0644(6)Å b=7.5770(7)Å c=23.8053(10)Å
α=90° β=90° γ=90°
Methyl [6-(2-chlorobenzoyl)-2-oxo-2,3-dihydro-1,3-benzoxazol-3-yl]acetate
C17H12ClNO5
Acta Crystallographica Section E (2007) 63, 2 o787-o788
a=7.0189(5)Å b=10.0329(7)Å c=12.2791(8)Å
α=112.968(5)° β=95.782(5)° γ=95.013(5)°
2-[(2-furylmethyl)sulfanyl]-1H-3,1-benzimidazol-3-ium chloride dihydrate
C12H11N2OS,Cl,2(H2O)
Acta Crystallographica Section E (2007) 63, 5 o2433-o2433
a=7.0649(6)Å b=21.5994(17)Å c=9.5520(7)Å
α=90° β=97.925(6)° γ=90°
Methyl 2-[(1-oxo-1<i>H</i>-isochromen-3-yl)methyl]benzoate
C18H14O4
Acta Crystallographica Section E (2007) 63, 6 o2824-o2824
a=8.1628(7)Å b=8.8981(8)Å c=11.0236(9)Å
α=105.048(7)° β=108.266(6)° γ=97.981(7)°
<i>O</i>-Butyl S-(1,1,3-trioxobenz[<i>d</i>]isothiazol-2-yl)methyl dithiocarbonate
C13H15NO4S3
Acta Crystallographica Section E (2007) 63, 6 o2974-o2974
a=8.8191(3)Å b=13.4997(2)Å c=14.7531(2)Å
α=70.270(3)° β=85.255(5)° γ=89.696(5)°
2-[6-(4-Bromophenyl)imidazo[2,1-b]thiazol-3-yl]-N'-(1- ethylpropylidene)acetohydrazide
C18H19BrN4OS
Acta Crystallographica Section E (2007) 63, 7 o3103-o3103
a=6.9591(6)Å b=11.8636(10)Å c=13.1247(11)Å
α=65.411(6)° β=78.892(7)° γ=75.193(6)°
4-(4-Nitrophenyl)-3-phenoxyazetidin-2-one
C15H12N2O4
Acta Crystallographica Section E (2007) 63, 9 o3729-o3730
a=6.1548(7)Å b=9.8007(11)Å c=11.9296(13)Å
α=80.552(9)° β=75.167(9)° γ=82.188(9)°
2-(6-Oxo-3,4-diphenyl-1,6-dihydropyridazin-1-yl)acetic acid
C18H14N2O3
Acta Crystallographica Section E (2007) 63, 12 o4522-o4522
a=10.3646(11)Å b=10.3410(9)Å c=15.5884(17)Å
α=90° β=109.721(8)° γ=90°
4-[(2-Hydroxy-1-naphthyl)methylideneamino]benzoic acid
C18H13NO3
Acta Crystallographica Section E (2008) 64, 4 o682
a=14.7490(12)Å b=4.9850(4)Å c=36.750(3)Å
α=90° β=91.3050(10)° γ=90°
Ethyl 5-acetyl-2-amino-4-methylthiophene-3-carboxylate
C10H13NO3S
Acta Crystallographica Section E (2008) 64, 6 o1084
a=7.5397(3)Å b=8.4514(3)Å c=16.7058(6)Å
α=90° β=94.4650(10)° γ=90°
Trans,trans,trans-1,4-Dimethoxy-2,3,5,8-tetrabromo-1,2,3,4-tetrahydronaphthalene
C12H12Br4O2
Acta Crystallographica Section E (2006) 62, 10 o4609-o4610
a=17.546(5)Å b=12.522(5)Å c=7.405(5)Å
α=90° β=113.207(5)° γ=90°
1-cyclohexylmethyl-3-methyl-2-[(phenylimino)(sulfido)methyl]benzimidazolium
C22H25N3S
Acta Crystallographica Section E (2008) 64, 5 o809
a=11.0999(8)Å b=12.4601(7)Å c=15.0143(14)Å
α=90° β=99.007(7)° γ=90°
<i>N</i>-(3-Oxo-1-thia-4-azaspiro[4.5]dec-4-yl)-6- phenylimidazo[2,1-<i>b</i>][1,3]thiazole-3-acetamide hemihydrate
C21H22N4O2S2,0.5(H2O)
Acta Crystallographica Section E (2008) 64, 5 o810-o811
a=11.0175(3)Å b=11.8817(3)Å c=17.6162(5)Å
α=75.123(2)° β=73.502(2)° γ=81.012(2)°
Methyl 2-(2-hydroxybenzylideneamino)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate
C17H17NO3S
Acta Crystallographica Section E (2008) 64, 5 o869
a=7.6107(4)Å b=21.2154(9)Å c=11.1827(7)Å
α=90° β=123.342(4)° γ=90°
2-[1-(4-Ethoxyphenyl)-2-oxo-4-styrylazetidin-3-yl]isoindoline-1,3-dione
C27H22N2O4
Acta Crystallographica Section E (2008) 64, 5 o924
a=33.7560(17)Å b=7.0403(2)Å c=31.0482(17)Å
α=90° β=140.454(3)° γ=90°
4-(9-Anthryl)-1-(4-methoxyphenyl)spiro[azetidin-3,9'-xanthen]-2-one
C36H25NO3
Acta Crystallographica Section E (2008) 64, 5 o902-o903
a=13.7629(9)Å b=10.5845(4)Å c=20.5777(12)Å
α=90° β=114.768(5)° γ=90°
<i>N</i>-(2,6-Dimethyl-3-oxo-1-thia-4-azaspiro[4.5]dec-4-yl)-2-hydroxy-2,2- diphenylacetamide
C24H28N2O3S
Acta Crystallographica Section E (2008) 64, 10 o1919
a=9.4942(4)Å b=20.6765(5)Å c=12.0052(4)Å
α=90° β=105.063(2)° γ=90°
<i>trans</i>-<i>rac</i>-[1-Oxo-2-phenethyl-3-(2-thienyl)-1,2,3,4-\ tetrahydroisoquinolin-4-yl]methyl 4-methylbenzenesulfonate
C29H27NO4S2
Acta Crystallographica Section E (2008) 64, 10 o1955-o1956
a=7.2529(3)Å b=8.6727(4)Å c=20.9899(10)Å
α=86.021(4)° β=87.396(4)° γ=78.330(4)°
8-Ethyl-2-hydroxy-2-methyl-4-morpholinoethyl-1-thia- 4-azaspiro[4.5]decan-3-one
C17H30N2O3S
Acta Crystallographica Section E (2008) 64, 10 o1939-o1940
a=8.1878(4)Å b=10.2241(5)Å c=12.2188(6)Å
α=79.901(4)° β=73.796(4)° γ=67.674(4)°
1,1'-Butane-1,4-diylbis(1H-benzimidazole)
C18H18N4
Acta Crystallographica Section E (2007) 63, 2 o1065-o1066
a=5.6495(4)Å b=10.6323(7)Å c=12.7814(9)Å
α=90° β=99.042(6)° γ=90°
1-[(4-Methylbenzylidene)amino]-5-(4-methylbenzoyl)-4-(p-tolyl)pyrimidin- 2(1H)-one
C27H23N3O2
Acta Crystallographica Section E (2007) 63, 4 o1857-o1858
a=13.9829(7)Å b=12.0458(7)Å c=16.4807(9)Å
α=90° β=125.831(3)° γ=90°
Diethyl 2-[morpholin-4-yl(phenyl)methyl]malonate
C18H25NO5
Acta Crystallographica Section E (2007) 63, 4 o1656-o1657
a=9.1421(6)Å b=11.5978(7)Å c=17.1379(15)Å
α=90° β=90° γ=90°
2-[2-(4-Benzylpiperazin-1-ylcarbonyl)ethyl]-5,6-diphenylpyridazin-3(2H)-one
C30H30N4O2
Acta Crystallographica Section E (2008) 64, 6 o1030
a=15.6725(12)Å b=9.1139(5)Å c=17.6743(12)Å
α=90° β=90.553(6)° γ=90°
<i>rac</i>-2-Hydroxy-2,8-dimethyl-4-morpholinoethyl-1-thia-4- azaspiro[4.5]decan-3-one
C16H28N2O3S
Acta Crystallographica Section E (2008) 64, 8 o1574-o1575
a=8.0753(4)Å b=10.2002(5)Å c=11.8734(6)Å
α=82.467(4)° β=71.487(4)° γ=68.965(4)°
8-Methyl-4-morpholinoethyl-1-thia-4-azaspiro[4.5]decan-3-one
C15H26N2O2S
Acta Crystallographica Section E (2008) 64, 8 o1572-o1573
a=7.8629(4)Å b=10.5239(6)Å c=10.8252(6)Å
α=94.974(5)° β=106.378(5)° γ=107.169(4)°
(1RS,2RS,3SR,4SR,9RS)-1,2,3,9-Tetrabromo-1,2,3,4-tetrahydro- 1,4-methanonaphthalene
C11H8Br4
Acta Crystallographica Section E (2006) 62, 8 o3483-o3485
a=6.62200(10)Å b=13.6490(3)Å c=13.7350(3)Å
α=90° β=92.0790(10)° γ=90°
Dimethyl N-(4-phenyl-1,3-thiazol-2-yl)dithioimidocarbonate
C12H12N2S3
Acta Crystallographica Section E (2006) 62, 9 o3902-o3903
a=7.66260(10)Å b=18.2969(3)Å c=19.4176(3)Å
α=90° β=90° γ=90°
(+-)-Methyl 1-oxo-1<i>H</i>-spiro[benzo[c]pyran-3(4H),1'-cyclohexane]-4-carboxylate
C16H18O4
Acta Crystallographica Section E (2007) 63, 3 o1321-o1323
a=8.2647(9)Å b=14.0850(11)Å c=12.1150(14)Å
α=90° β=95.573(9)° γ=90°
5-(4-Methylbenzoyl)-4-(4-methylphenyl)-1-[(1-phenylethylidene)amino]pyrimidin- 2(1H)-one
C27H23N3O2
Acta Crystallographica Section E (2007) 63, 4 o1712-o1713
a=13.6001(7)Å b=17.1608(10)Å c=10.8703(5)Å
α=90° β=111.351(4)° γ=90°
2-Hydroxy-N-(3-oxo-1-thia-4-azaspiro[4.5]dec-4-yl)-2,2-diphenylacetamide
C22H24N2O3S
Acta Crystallographica Section E (2007) 63, 8 o3379-o3380
a=12.1676(2)Å b=9.3050(2)Å c=17.9081(3)Å
α=90° β=95.4236(11)° γ=90°
(E)-2-[1-(2,4-Dimethoxyphenylimino)ethyl]phenol
C16H17NO3
Acta Crystallographica Section E (2007) 63, 8 o3597-o3597
a=11.0449(8)Å b=9.1047(4)Å c=15.7750(10)Å
α=90° β=118.190(5)° γ=90°
2-[(E)-4-Quinolylmethylideneamino]phenol
C16H12N2O
Acta Crystallographica Section E (2008) 64, 11 o2168
a=6.7174(6)Å b=23.931(2)Å c=7.7495(6)Å
α=90° β=105.5210(10)° γ=90°
3,4-Dimethoxy-<i>N</i>-(3-nitrobenzylidene)aniline
C15H14N2O4
Acta Crystallographica Section E (2008) 64, 11 o2175-o2176
a=8.6345(8)Å b=8.6540(8)Å c=19.2304(17)Å
α=96.629(7)° β=97.338(7)° γ=102.075(7)°
1,3-Bis(3-phenylpropyl)benzimidazolium bromide monohydrate
C25H27N2,Br,H2O
Acta Crystallographica Section E (2008) 64, 10 o2019-o2020
a=14.1933(8)Å b=11.4594(3)Å c=18.3014(10)Å
α=90° β=128.916(3)° γ=90°
Di-μ-iodido- bis{[(4-fluorobenzoylmethylene)triphenyl-λ^5^-phosphorane]iodidomercury(II)}
C52H40F2Hg2I4O2P2
Acta Crystallographica Section E (2008) 64, 5 m612-m613
a=10.0346(16)Å b=11.8594(19)Å c=13.235(2)Å
α=92.513(13)° β=111.293(12)° γ=113.117(12)°
3-[6-(2-Chlorobenzoyl)-2-oxo-2,3-dihydro-1,3-benzothiazol-3-yl]propanenitrile
C17H11ClN2O2S
Acta Crystallographica Section E (2006) 62, 12 o5933-o5934
a=7.0890(10)Å b=8.5220(10)Å c=26.042(2)Å
α=97.724(6)° β=91.659(6)° γ=93.257(6)°
5,5a-Diallyl-5,5a,13,14-tetrahydro-12H-di-1,3- benzimidazolo[1,2-a;1',2'-c][1,4]diazepine
C23H24N4
Acta Crystallographica Section E (2006) 62, 12 o5697-o5698
a=25.1810(13)Å b=8.304(5)Å c=8.878(8)Å
α=90° β=90° γ=90°
1,3-Bis(2-chlorobenzoyl)-3,4,5,6-tetrahydropyrimidine-2(1H)-thione
C18H14Cl2N2O2S
Acta Crystallographica Section E (2006) 62, 9 o3697-o3698
a=11.361(5)Å b=12.917(5)Å c=12.186(5)Å
α=90° β=95.399(5)° γ=90°
1-(4-Chlorobenzyl)-3-[2-(pyrrolidinium-1-yl)ethyl]benzimidazolium dichloride monohydrate
C20H24ClN32,2(Cl),H2O
Acta Crystallographica Section E (2007) 63, 1 o379-o381
a=15.3427(8)Å b=6.8703(2)Å c=21.7329(11)Å
α=90° β=111.355(4)° γ=90°
1,1,3-Trioxo-2,3-dihydro-1,2-benzisothiazol-2-ylmethyl 4-phenylpiperazine-1-carbodithioate
C19H19N3O3S3
Acta Crystallographica Section E (2007) 63, 8 o3383-o3383
a=8.0390(5)Å b=11.7619(7)Å c=11.8796(8)Å
α=109.029(5)° β=103.791(5)° γ=102.326(5)°
N-(2-{[(1E)-1-(2-Hydroxyphenyl)ethylidene]amino}phenyl)-2-methoxyacetamide
C17H18N2O3
Acta Crystallographica Section E (2007) 63, 8 o3478-o3479
a=8.4061(8)Å b=11.2568(5)Å c=16.4145(16)Å
α=90° β=98.988(8)° γ=90°
1,3-Bis(3-phenylpropyl)1H-benzimidazole-2(3H)-tellurone
C25H26N2Te
Acta Crystallographica Section E (2008) 64, 3 o621-o622
a=10.6004(2)Å b=10.6004(2)Å c=20.4365(6)Å
α=90° β=90° γ=90°
Diethyl 5-[(2-hydroxy-1-naphthyl)methylideneamino]-3-methylthiophene-2,4-dicarboxylate
C22H21NO5S
Acta Crystallographica Section E (2008) 64, 5 o923
a=8.7111(4)Å b=11.5319(5)Å c=11.9778(5)Å
α=61.594(3)° β=79.489(3)° γ=89.334(3)°
<i>trans</i>-<i>rac</i>-Methyl 2-hexyl-1-oxo-3-(2-pyridyl)-1,2,3,4-tetrahydro- isoquinoline-4-carboxylate
C22H26N2O3
Acta Crystallographica Section E (2008) 64, 10 o1932
a=8.8404(2)Å b=15.6719(5)Å c=29.1488(10)Å
α=90° β=90° γ=90°
(<i>E</i>)-1,1-Bis[(<i>E</i>)-but-2-enyl]-3,3'-(propane-1,3-\ diyl)bis(1<i>H</i>-benzimidazol-3-ium) dibromide monohydrate
C25H30N42,2(Br),H2O
Acta Crystallographica Section E (2008) 64, 11 o2136-o2137
a=8.7989(9)Å b=11.1878(13)Å c=14.8813(14)Å
α=106.381(8)° β=96.490(8)° γ=106.227(8)°
(2<i>E</i>)-1-(2,4-Dichlorophenyl)-3-[4-(prop-1-en-2-yl)phenyl]prop-2-en-1-one
C18H14Cl2O
Acta Crystallographica Section C (2015) 71, 7
a=13.4314(4)Å b=8.2405(4)Å c=29.9252(9)Å
α=90° β=90° γ=90°
(5<i>RS</i>)-3-(4-Chlorophenyl)-5-[4-(propan-2-yl)phenyl]cyclohex-2-en-1-one
C21H21ClO
Acta Crystallographica Section C (2015) 71, 7
a=6.6259(8)Å b=8.6868(11)Å c=30.472(4)Å
α=90° β=91.765(4)° γ=90°
4-[1-(2-Hydroxypropyl)-4,5-diphenyl-1<i>H</i>-imidazol-2-yl]benzoic acid
C25H22N2O3
Acta Crystallographica Section E Crystallographic Communications (2015) 71, 2 o77
a=6.8710(4)Å b=10.7188(6)Å c=14.9178(7)Å
α=103.569(4)° β=93.094(4)° γ=105.878(5)°
4-[(<i>E</i>)-(4-Nitrobenzylidene)amino]phenol
C13H10N2O3
Acta Crystallographica Section E Crystallographic Communications (2015) 71, 2 o113
a=12.3449(6)Å b=13.4266(6)Å c=15.7404(7)Å
α=72.926(4)° β=67.390(4)° γ=76.824(4)°
2-[2-(4-Chlorophenyl)-1-(4-methoxyphenyl)-4-oxoazetidin-3-yl]benzo[<i>de</i>]isoquinoline-1,3-dione dimethyl sulfoxide monosolvate
C28H19ClN2O4,C2H6OS
Acta Crystallographica Section E Crystallographic Communications (2015) 71, 2 o129
a=7.9925(3)Å b=12.1761(5)Å c=14.2313(6)Å
α=93.549(2)° β=95.520(2)° γ=101.602(2)°
3-Acetyl-4-benzoyl-2-methyl-5-phenyl-3,3a-dihydropyrazolo[2,3-c]pyrimidine- 7(6H)-thione
C22H19N3O2S
Acta Crystallographica Section C (2000) 56, 6 e276-e277
a=6.9505(3)Å b=21.8820(8)Å c=12.9619(5)Å
α=90.00° β=100.2390(10)° γ=90.00°
Pseudokobusine
C20H27NO3
Acta Crystallographica Section C (2001) 57, 4 500-500
a=8.0746(8)Å b=11.4613(11)Å c=9.1121(9)Å
α=90° β=90.338(2)° γ=90°
Methyl (+-)-1-ethyl-2-hydroxy-4-(4-methoxybenzoyl)-5-(4-methoxyphenyl)-3-oxo- 2,3-dihydro-1H-pyrrole-2-acetate
C24H25NO7
Acta Crystallographica Section C (2003) 59, 10 o598-o600
a=10.160(5)Å b=10.785(5)Å c=11.942(5)Å
α=66.369(5)° β=75.928(5)° γ=72.005(5)°
(2<i>Z</i>)-2-(4-Methylphenyl)-3-(2-naphthyl)prop-2-enenitrile
C20H15N
Acta Crystallographica Section E (2009) 65, 10 o2409
a=12.3194(11)Å b=16.4796(16)Å c=7.2596(7)Å
α=90° β=90° γ=90°
3-Carbamothioylpyridinium iodide
C6H7N2S,I
Acta Crystallographica Section E (2009) 65, 10 o2423
a=4.4024(3)Å b=8.1943(5)Å c=12.6815(8)Å
α=102.485(2)° β=96.496(2)° γ=102.288(2)°
Bis(1-butyl-3-propylthiourea)dicyanidomercury(II)
C20H40HgN6S2
Acta Crystallographica Section E (2009) 65, 10 m1191-m1192
a=17.4692(3)Å b=9.5928(2)Å c=17.4699(4)Å
α=90° β=111.5400(10)° γ=90°
4-Methyl-<i>N</i>-(2-oxo-1-phenylethyl)benzenesulfonamide
C15H15NO4S
Acta Crystallographica Section E (2009) 65, 11 o2797
a=5.6592(12)Å b=11.208(2)Å c=23.342(4)Å
α=90° β=90° γ=90°
4-(9-Anthryl)-1-(1-naphthyl)spiro[azetidine-3,9'-xanthen]-2-one n-hexane hemisolvate
C39H25NO2,0.5(C6H14)
Acta Crystallographica Section E (2008) 64, 12 o2466-o2467
a=12.0788(5)Å b=14.1379(5)Å c=18.6133(8)Å
α=90° β=107.216(3)° γ=90°
1-(4-Methoxyphenyl)-4-(3-nitrophenyl)-3-phenoxyazetidin-2-one
C22H18N2O5
Acta Crystallographica Section E (2011) 67, 2 o537-o538
a=7.7934(4)Å b=11.2813(3)Å c=11.8818(2)Å
α=77.771(4)° β=80.948(5)° γ=71.052(4)°
Bis[dichlorido(5,5-dimethyl-2,2'-bipyridine-κ^2^<i>N</i>,<i>N</i>')gold(III)] tetrachloridoaurate(III) dichloridooaurate(I)
2(C12H12AuCl2N2),AuCl4,AuCl2
Acta Crystallographica Section E (2009) 65, 3 m335-m336
a=9.0698(4)Å b=10.0886(4)Å c=11.1678(5)Å
α=91.155(4)° β=108.148(4)° γ=111.344(3)°
2-(4-Bromobenzenesulfonamido)benzoic acid
C13H10BrNO4S
Acta Crystallographica Section E (2009) 65, 7 o1610-o1611
a=27.8316(11)Å b=8.5684(4)Å c=11.6632(5)Å
α=90° β=98.196(2)° γ=90°
(<i>S</i>)-Methyl 2-[(3<i>R</i>,4<i>R</i>)-2-benzyl-3-(2-furyl)-1-oxo-1,2,3,4- tetrahydroisoquinoline-4-carboxamido]-3-(1<i>H</i>-indol-3-yl)propanoate
C33H29N3O5
Acta Crystallographica Section E (2009) 65, 7 o1461-o1462
a=8.6866(5)Å b=15.8630(7)Å c=10.5480(6)Å
α=90° β=104.543(5)° γ=90°
2-(4-Bromobenzenesulfonamido)-2-phenylacetic acid monohydrate
C14H12BrNO4S,H2O
Acta Crystallographica Section E (2009) 65, 8 o1953-o1954
a=5.5654(13)Å b=16.230(4)Å c=17.597(4)Å
α=90° β=90° γ=90°
Poly[hemi-μ-aqua-[μ-2-(2-bromobenzenesulfonamido)benzoato]sodium(I)]
Na,C13H9Br1N1O4S1,0.5(H2O1)
Acta Crystallographica Section E (2009) 65, 8 m982
a=9.1683(6)Å b=9.2722(5)Å c=18.4183(12)Å
α=97.717(2)° β=101.837(2)° γ=101.467(2)°
7-Benzenesulfonamido-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene- 2-carboxylic acid methanol solvate
C15H14N2O5S2,CH4O
Acta Crystallographica Section E (2009) 65, 8 o1737
a=12.0000(2)Å b=6.0964(8)Å c=13.602(2)Å
α=90° β=109.412(7)° γ=90°
1-Chloromethyl-3-nitrobenzene
C7H6ClNO2
Acta Crystallographica Section E (2010) 66, 3 o608
a=12.1219(10)Å b=4.5104(4)Å c=15.1219(11)Å
α=90° β=112.709(2)° γ=90°
3-<i>tert</i>-Butyl-1<i>H</i>-isochromene-1-thione
C13H14OS
Acta Crystallographica Section E (2010) 66, 6 o1470
a=43.2799(16)Å b=43.2799(16)Å c=6.9025(5)Å
α=90° β=90° γ=120°
3-Chloro-<i>N</i>-(4-sulfamoylphenyl)propanamide
C9H11ClN2O3S
Acta Crystallographica Section E (2010) 66, 7 o1559-o1560
a=7.7554(4)Å b=14.8191(8)Å c=9.7482(5)Å
α=90° β=94.181(4)° γ=90°